Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare complication of acute
pulmonary embolism, either symptomatic or not. The occlusion of proximal pulmonary …

determination and the implementation of preventive, diagnostic or therapeutic medical
strategies. However, the ESC Guidelines do not override in any way whatsoever the …

Pulmonary hypertension (PH) is a pathophysiological disorder that may involve multiple
clinical conditions and may be associated with a variety of cardiovascular and respiratory …

Chronic thromboembolic pulmonary hypertension (CTEPH) is a complication of pulmonary
embolism and a major cause of chronic PH leading to right heart failure and death. Lung …

Background Treprostinil, a prostacyclin analogue, is effective for the treatment of pulmonary
arterial hypertension. However, information is scarce regarding treprostinil for treatment of …

Chronic thromboembolic pulmonary hypertension (CTEPH) is the most severe long-term
complication of acute pulmonary embolism (PE). Untreated CTEPH is fatal, but, if diagnosed …

Background The influence of the new pulmonary hypertension (PH) definition on the
incidence of chronic thromboembolic PH (CTEPH) is unclear. The incidence of chronic …

Background Chronic thromboembolic pulmonary hypertension (CTEPH) is considered a
complication of pulmonary embolism (PE). However, signs of CTEPH may exist in patients …

Erratum: 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension:
Developed by the task force for the diagnosis and treatment of pulmonary hypertension of the …

Background The incidence and risk factors of chronic thromboembolic pulmonary
hypertension (CTEPH) after acute pulmonary embolism (PE) were still controversial. A …